المؤلفون: Thibault Butel, Marie Karanian, Gaelle Pierron, Daniel Orbach, Dominique Ranchere, Nathalie Cozic, Louise Galmiche, Aurore Coulomb, Nadège Corradini, Brigitte Lacour, Stéphanie Proust, Florent Guerin, Hélène Boutroux, Angélique Rome, Ludovic Mansuy, Cécile Vérité, Anne‐Sophie Defachelles, Franck Tirode, Veronique Minard‐Colin

المصدر: Cancer Medicine, Vol 9, Iss 8, Pp 2698-2709 (2020)

مصطلحات موضوعية: infants, newborns, rhabdoid tumor, rhabdomyosarcoma, spindle cell rhabdomyosarcoma, VGLL2, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

Relation: https://doaj.org/toc/2045-7634

URL الوصول: https://doaj.org/article/7f284104dd42443dbd8e58dbdbca3e3e

المؤلفون: Arnaud Picard, Marie-Cécile Le Deley, Natacha Kadlub, Celine Mahier Ait Oukhatar, Frédéric Kolb, J. Bouaoud, Quentin Qassemyar, Stéphane Temam, François Bidault, Nathalie Gaspar, Kahina Belhous, Nathalie Cozic Stephanie Bolle, Vincent Couloigner, Louise Galmiche

المصدر: Journal of Cranio-Maxillofacial Surgery. 50:439-448

مصطلحات موضوعية: Poor prognosis, medicine.medical_specialty, medicine.medical_treatment, Postoperative radiotherapy, Context (language use), Sarcoma, Ewing, Esthetics, Dental, Malignancy, 03 medical and health sciences, 0302 clinical medicine, medicine, Humans, Head and neck, Retrospective Studies, Chemotherapy, business.industry, Margins of Excision, Neoplasms, Second Primary, 030206 dentistry, medicine.disease, Combined Modality Therapy, Surgery, Radiation therapy, Otorhinolaryngology, Head and Neck Neoplasms, 030220 oncology & carcinogenesis, Sarcoma, Neoplasm Recurrence, Local, Oral Surgery, business

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eaf7f9f49b715dc926a70b2932031a20
https://doi.org/10.1016/j.jcms.2021.01.030

المؤلفون: Diana Saravia, Andrew J. Plodkowski, Annapaola Mariniello, Benjamin Besse, Lizza E.L. Hendriks, Maria Lucia Reale, Fabrizio Tabbò, Gilberto Lopes, Lydie Cassard, Anne-Marie C. Dingemans, Kathryn C. Arbour, Matthew D. Hellmann, Margarita Majem, Hira Rizvi, Edouard Auclin, Jeffrey Girshman, Silvia Novello, M. Naigeon, Simona Carnio, Nathalie Cozic, F. Blanc-Durand, Laura Mezquita, Clarisse Audigier-Valette, Peter Sawan, Paolo Bironzo, Nathalie Chaput, Jose Carlos Ruffinelli, Luis Paz-Ares, Patricia Martin-Romano, Ernest Nadal, Melinda Charrier, Wungki Park, Isabel Ruth Preeshagul, David Planchard, Santiago Ponce, Gérard Zalcman, Caroline Rossoni

المساهمون: Pulmonologie, MUMC+: MA Med Staf Spec Longziekten (9), RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy, Pulmonary Medicine

المصدر: EUROPEAN JOURNAL OF CANCER
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
Instituto de Salud Carlos III (ISCIII)
European Journal of Cancer, 151, 211-220. ELSEVIER SCI LTD
European Journal of Cancer, 151, 211-220. Elsevier Ltd.

مصطلحات موضوعية: 0301 basic medicine, Oncology, Male, Cancer Research, Lung Neoplasms, Time Factors, Neutrophils, medicine.medical_treatment, NSCLC, Leukocyte Count, 0302 clinical medicine, Immunophenotyping, MARKERS, Carcinoma, Non-Small-Cell Lung, Prospective Studies, Immune Checkpoint Inhibitors, DOCETAXEL, Aged, 80 and over, Middle Aged, Flow Cytometry, Europe, Phenotype, Treatment Outcome, Docetaxel, 030220 oncology & carcinogenesis, Biomarker (medicine), Female, Immunotherapy, Biomarker, dNLR, Nivolumab, medicine.drug, Adult, medicine.medical_specialty, BIOMARKERS, 03 medical and health sciences, Young Adult, SDG 3 - Good Health and Well-being, Predictive Value of Tests, Internal medicine, medicine, Humans, In patient, CELL, Lung cancer, Aged, Retrospective Studies, business.industry, NIVOLUMAB, medicine.disease, United States, 030104 developmental biology, Biological significance, Drug Resistance, Neoplasm, INHIBITORS, business

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4a96c55a9d472fb0598bd6fb82e8dace
https://doi.org/10.1016/j.ejca.2021.03.011

المؤلفون: Nathalie Gaspar, Marie-Cécile Le Deley, Dominique Plantaz, Kahina Belhous, Nathalie Cozic, Vincent Couloigner, Stéphanie Bolle, Quentin Quassemyar, François Bidault, Stéphane Temam, Sarah Dumont, Natacha Kadlub, Marie-Dominique Tabone, Louise Galmiche-Rolland, Valérie Laurence, Jebrane Bouaoud, Perrine Marec-Berard, Anne Gomez-Brouchet, Celine Mahier Ait Oukhatar, Frédéric Kolb, Arnaud Picard

المصدر: Cancer Medicine

مصطلحات موضوعية: surgical margins, Adult, Male, long‐term sequeals, Cancer Research, medicine.medical_specialty, Adolescent, medicine.medical_treatment, Antineoplastic Agents, Bone Neoplasms, Sarcoma, Ewing, Metastasis, head and neck, Young Adult, 03 medical and health sciences, 0302 clinical medicine, Port (medical), local treatment, medicine, Humans, Radiology, Nuclear Medicine and imaging, Child, 030223 otorhinolaryngology, Head and neck, Pathological, Original Research, Chemotherapy, business.industry, Clinical Cancer Research, Infant, Margins of Excision, Ewing's sarcoma, medicine.disease, Surgery, Radiation therapy, Oncology, Head and Neck Neoplasms, Child, Preschool, 030220 oncology & carcinogenesis, Maxilla, Female, Ewing’s sarcoma, business

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ee20d4a8af4f4af9ef5604e620e2511c
https://doi.org/10.1002/cam4.1801

المؤلفون: Rosine Guimbaud, Carlos Gomez-Roca, Laurent Mineur, Thomas Aparicio, Emmanuelle Samalin, Gilles Vassal, Jannick Selves, Christelle De La Fouchardiere, Paul Arthur Haineaux, Yves Menu, Florence Mary, Alain Gratet, Nathalie Cozic, N. Colignon, Jérôme Edouard Plaza, Laetitia Johnson, Frédéric Legrand, Emeline Meriaux, Thierry Lecomte

المساهمون: Gestionnaire, Hal Sorbonne Université, Hopital Saint-Louis [AP-HP] (AP-HP), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Institut Gustave Roussy (IGR), Service de biostatistique et d'épidémiologie (SBE), Direction de la recherche clinique [Gustave Roussy], Institut Gustave Roussy (IGR)-Institut Gustave Roussy (IGR), Centre de recherche en épidémiologie et santé des populations (CESP), Université de Versailles Saint-Quentin-en-Yvelines (UVSQ)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Paul Brousse-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris-Saclay, Centre Léon Bérard [Lyon], Centre de Recherche en Cancérologie de Lyon (UNICANCER/CRCL), Centre Léon Bérard [Lyon]-Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Institut de Cancérologie de l'Ouest [Angers/Nantes] (UNICANCER/ICO), UNICANCER, CRLCC René Gauducheau, Centre Hospitalier Universitaire de Toulouse (CHU Toulouse), Institut du Cancer de Montpellier (ICM), Hôpital Avicenne [AP-HP], Nutrition, croissance et cancer (U 1069) (N2C), Université de Tours (UT)-Institut National de la Santé et de la Recherche Médicale (INSERM), Institut Claudius Regaud, Institut Universitaire du Cancer de Toulouse - Oncopole (IUCT Oncopole - UMR 1037), Université Toulouse III - Paul Sabatier (UT3), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-Centre Hospitalier Universitaire de Toulouse (CHU Toulouse)-Institut National de la Santé et de la Recherche Médicale (INSERM), Centre hospitalier universitaire de Poitiers (CHU Poitiers), Clinique Pasteur [Toulouse], CHU Saint-Antoine [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Institut national du cancer [Boulogne] (INCA), Analyse moléculaire, modélisation et imagerie de la maladie cancéreuse (AMMICa), Institut Gustave Roussy (IGR)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris-Saclay-Centre National de la Recherche Scientifique (CNRS), Département de cancérologie de l'enfant et de l'adolescent [Gustave Roussy], Université de Lyon-Université de Lyon-Centre National de la Recherche Scientifique (CNRS)-Institut National de la Santé et de la Recherche Médicale (INSERM), CHU Toulouse [Toulouse], CHU Toulouse [Toulouse]-Université Toulouse III - Paul Sabatier (UT3), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-Institut National de la Santé et de la Recherche Médicale (INSERM), Université de Tours-Institut National de la Santé et de la Recherche Médicale (INSERM), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-CHU Toulouse [Toulouse]-Institut National de la Santé et de la Recherche Médicale (INSERM)

المصدر: Targeted Oncology
Targeted Oncology, 2021, ⟨10.1007/s11523-021-00811-8⟩
Targeted Oncology, Springer Verlag (Germany), 2021, ⟨10.1007/s11523-021-00811-8⟩

مصطلحات موضوعية: 0301 basic medicine, Adult, Cancer Research, medicine.medical_specialty, Esophageal Neoplasms, [SDV]Life Sciences [q-bio], Met amplification, Adenocarcinoma, Gastroenterology, 03 medical and health sciences, 0302 clinical medicine, Refractory, Crizotinib, Stomach Neoplasms, Internal medicine, medicine, Humans, Pharmacology (medical), In patient, Prospective Studies, Original Research Article, Protein Kinase Inhibitors, Aged, Aged, 80 and over, medicine.diagnostic_test, business.industry, Middle Aged, medicine.disease, 3. Good health, [SDV] Life Sciences [q-bio], 030104 developmental biology, Oncology, Tolerability, 030220 oncology & carcinogenesis, Immunohistochemistry, business, Fluorescence in situ hybridization, medicine.drug

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ee4872607fd0c2fa815ea047e349b645
https://pubmed.ncbi.nlm.nih.gov/33847874

المؤلفون: Denis Moro-Sibilot, Renaud Sabatier, Alexis B. Cortot, Gérard Zalcman, S.D. Guibert, Fabrice Barlesi, Maurice Pérol, J. Otto, Ratislav Bahleda, Gilles Vassal, P.J. Souquet, Marta Jimenez, Nathalie Cozic, Gilbert Ferretti, Bertrand Mennecier, N. Hoog-Labouret, S. Bota, Marie Wislez, F. De Fraipont, Véronique Haddad, Julien Mazieres, C. Dubos, V. Verriele, Isabelle Monnet

المساهمون: Institut d'oncologie/développement Albert Bonniot de Grenoble (INSERM U823), Université Joseph Fourier - Grenoble 1 (UJF)-CHU Grenoble-EFS-Institut National de la Santé et de la Recherche Médicale (INSERM), Service de biostatistique et d'épidémiologie (SBE), Direction de la recherche clinique [Gustave Roussy], Institut Gustave Roussy (IGR)-Institut Gustave Roussy (IGR), Département cancer environnement (Centre Léon Bérard - Lyon), Centre Léon Bérard [Lyon], Service de pneumologie [Toulouse], Centre Hospitalier Universitaire de Toulouse (CHU Toulouse), Centre de Lutte contre le Cancer Antoine Lacassagne [Nice] (UNICANCER/CAL), UNICANCER-Université Côte d'Azur (UCA), Service de pneumologie [Centre Hospitalier Lyon Sud - HCL], Centre Hospitalier Lyon Sud [CHU - HCL] (CHLS), Hospices Civils de Lyon (HCL)-Hospices Civils de Lyon (HCL), CHU Tenon [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Intergroupe Francophone de Cancérologie Thoracique [Paris] (IFCT), Intergroupe Francophone de Cancérologie thoracique, Service d'oncologie multidisciplinaire innovations thérapeutiques [Hôpital Nord - APHM], Assistance Publique - Hôpitaux de Marseille (APHM)- Hôpital Nord [CHU - APHM], Centre de Recherche en Cancérologie de Marseille (CRCM), Aix Marseille Université (AMU)-Institut Paoli-Calmettes, Fédération nationale des Centres de lutte contre le Cancer (FNCLCC)-Fédération nationale des Centres de lutte contre le Cancer (FNCLCC)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Service de Pneumologie [CHI Créteil], CHI Créteil, Service de pneumologie, oncologie thoracique et soins intensifs respiratoires [Rouen], Hôpital Charles Nicolle [Rouen], CHU Rouen, Normandie Université (NU)-Normandie Université (NU)-CHU Rouen, Normandie Université (NU)-Normandie Université (NU)-Université de Rouen Normandie (UNIROUEN), Normandie Université (NU), Laboratoire de Bactériologie CHU de Rouen, Centre de Recherche en Cancérologie de Lyon (UNICANCER/CRCL), Centre Léon Bérard [Lyon]-Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Institut Gustave Roussy (IGR), CHU Toulouse [Toulouse]-Hôpital Larrey [Toulouse], CHU Toulouse [Toulouse], Service de Pneumologie - Oncologie Thoracique - Maladies Pulmonaires Rares [CHU Tenon], Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Centre National de la Recherche Scientifique (CNRS)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Institut Paoli-Calmettes, Fédération nationale des Centres de lutte contre le Cancer (FNCLCC)-Fédération nationale des Centres de lutte contre le Cancer (FNCLCC)-Aix Marseille Université (AMU), Hôpital Charles Nicolle [Rouen]-CHU Rouen

المصدر: Annals of Oncology
Annals of Oncology, 2019, 30 (12), pp.1985-1991. ⟨10.1093/annonc/mdz407⟩
Annals of Oncology, Elsevier, 2019, 30 (12), pp.1985-1991. ⟨10.1093/annonc/mdz407⟩

مصطلحات موضوعية: 0301 basic medicine, Oncology, Male, Oncogene Proteins, Fusion, medicine.medical_treatment, [SDV]Life Sciences [q-bio], ROS1 fusion, Phases of clinical research, Targeted therapy, 0302 clinical medicine, Carcinoma, Non-Small-Cell Lung, Molecular Targeted Therapy, Aged, 80 and over, Gene Rearrangement, Hematology, Middle Aged, Protein-Tyrosine Kinases, Proto-Oncogene Proteins c-met, targeted therapy, Progression-Free Survival, 3. Good health, 030220 oncology & carcinogenesis, Cohort, Female, medicine.drug, Adult, medicine.medical_specialty, [SDV.BC]Life Sciences [q-bio]/Cellular Biology, Disease-Free Survival, 03 medical and health sciences, Internal medicine, Proto-Oncogene Proteins, medicine, ROS1, Humans, Lung cancer, Protein Kinase Inhibitors, Aged, crizotinib, Crizotinib, business.industry, c-MET-mutation, Cancer, medicine.disease, c-MET amplification, Clinical trial, lung cancer, 030104 developmental biology, Mutation, business

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::487217358f47df224fa568af23e7e11c
https://hal.science/hal-02530381

المؤلفون: Lisa Belin, Nicolas Boccheciampe, Noël Zahr, Jean-Sébastien Hulot, Olivier Langeron, Frédéric Aubrun, Nathalie Cozic, Bruno Riou, Frédéric Khiami

المصدر: European Journal of Anaesthesiology. 35:496-504

مصطلحات موضوعية: Male, ATP Binding Cassette Transporter, Subfamily B, medicine.drug_class, Analgesic, Receptors, Opioid, mu, Catechol O-Methyltransferase, Polymorphism, Single Nucleotide, Pacu, 03 medical and health sciences, 0302 clinical medicine, 030202 anesthesiology, Opioid receptor, medicine, Humans, Pain Management, Prospective Studies, Adverse effect, Aged, Aged, 80 and over, Pain, Postoperative, Morphine, biology, business.industry, Chronic pain, Middle Aged, biology.organism_classification, medicine.disease, Analgesics, Opioid, Anesthesiology and Pain Medicine, Opioid, Anesthesia, Pharmacodynamics, Female, business, 030217 neurology & neurosurgery, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4c2d7772b380e6b1c8cd557ba70e8919
https://doi.org/10.1097/eja.0000000000000793

المؤلفون: Daniel Orbach, Soledad Gallego, Meriel Jenney, Nathalie Cozic, Johanna H. van der Lee, Bas Vaarwerk, Christine Devalck, Johannes H. M. Merks, Willemijn B. Breunis, Anna Kelsey, Michael C. Stevens, Kieran McHugh, Odile Oberlin, Rick R. van Rijn, Mark N. Gaze, Julia C. Chisholm, Christophe Bergeron, Heidi Glosli, Veronique Minard-Colin

المصدر: Cancer. 124:1016-1024

مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, Chemotherapy, business.industry, Proportional hazards model, medicine.medical_treatment, Hazard ratio, Induction chemotherapy, Cancer, medicine.disease, Pediatric cancer, 030218 nuclear medicine & medical imaging, 03 medical and health sciences, 0302 clinical medicine, 030220 oncology & carcinogenesis, Internal medicine, medicine, Rhabdomyosarcoma, business, Progressive disease

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::546b5aaacca25349e2c8c872ad917899
https://doi.org/10.1002/cncr.31157

المؤلفون: D. Waast, K. Malekzadeh, Christine Chevreau, Sophie Piperno-Neumann, J-Y. Blay, L. Lam, P. Anract, A. Michot, Florence Duffaud, S. Bonvalot, A. Le Cesne, C. Le Pechoux, Nicolas Penel, Nathalie Cozic, Charles Honoré

المصدر: Annals of Oncology. 32:S1113

مصطلحات موضوعية: medicine.medical_specialty, Oncology, business.industry, Observational Trial, Internal medicine, Medicine, Hematology, business, Peripheral

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::bd1cfdf53ef8d3273e5df53f45f80e79
https://doi.org/10.1016/j.annonc.2021.08.853

المؤلفون: Fabrice Barlesi, Nathalie Cozic, L. Moreau, Henri Berard, Denis Moro-Sibilot, Ludovic Lacroix, Julien Mazieres, Radj Gervais, Cécile Jovelet, Jean-Charles Soria, Elodie Amour, Benjamin Besse, Pierre Jean Souquet, Gérard Zalcman, Virginie Westeel, Olivier Molinier, Jaafar Bennouna, Franck Morin, D. Vasseur

المصدر: Journal of Clinical Oncology. 39:8526-8526

مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, business.industry, medicine.medical_treatment, Minimal residual disease, Circulating biomarkers, Internal medicine, medicine, Micrometastatic disease, In patient, business, Adjuvant

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::32ebb56c5acebd3f0fca5e5ac962e325
https://doi.org/10.1200/jco.2021.39.15_suppl.8526